A higher weekly dose of semaglutide helped adults with obesity lose about 19 percent of their body weight, and it did so over a long, carefully monitored period that followed strict protocols and consistent follow up visits
Safety monitoring parameters: Gastrointestinal tolerance: Keep a symptom diary during the first 8 weeks, noting severity and duration of nausea, vomiting, or diarrhea Hydration status: Monitor for signs of dehydration, especially if experiencing gastrointestinal side effects Abdominal symptoms: Report persistent or severe abdominal pain promptly for evaluation of potential pancreatitis or gallbladder disease Renal function: Assess at baseline and periodically per ADA guidelines (at least annually
How can PlexusDx's Precision Peptide Genetic Test help me optimize exercise and weight loss
Although neuroimaging studies have largely examined obesity and AUD phenotypes separately, their findings are generally overlapping and, within the limitations of neuroimagings spatial and temporal resolution, highly consistent with the preclinical studies reviewed above
Within another year, or a year or so later, we had this whole thing figured out